Prestige Consumer Healthcare Inc.
PBH · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,272 | $3,567 | $3,124 | $2,661 |
| - Cash | $98 | $46 | $58 | $27 |
| + Debt | $1,044 | $1,140 | $1,367 | $1,506 |
| Enterprise Value | $5,219 | $4,660 | $4,433 | $4,140 |
| Revenue | $1,138 | $1,125 | $1,128 | $1,087 |
| % Growth | 1.1% | -0.2% | 3.8% | – |
| Gross Profit | $634 | $624 | $625 | $621 |
| % Margin | 55.8% | 55.5% | 55.4% | 57.1% |
| EBITDA | $362 | $374 | $8 | $359 |
| % Margin | 31.8% | 33.2% | 0.7% | 33% |
| Net Income | $215 | $209 | -$82 | $205 |
| % Margin | 18.9% | 18.6% | -7.3% | 18.9% |
| EPS Diluted | 4.29 | 4.17 | -1.65 | 4.04 |
| % Growth | 2.9% | 352.7% | -140.8% | – |
| Operating Cash Flow | $252 | $249 | $230 | $260 |
| Capital Expenditures | -$8 | -$10 | -$8 | -$10 |
| Free Cash Flow | $243 | $239 | $222 | $250 |